Agenus Inc (AGEN)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current AGEN market cap is 128.59M. The company's latest EPS is USD -8.2952 and P/E is -0.57.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 84.36M | 28.01M | 23.51M | 25.11M | 30.79M |
| Operating Income | -3.8M | -32.88M | -30.19M | -33.37M | -24.03M |
| Net Income | -46.34M | -61.94M | -53.13M | -66.44M | -45.91M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 88.17M | 295.67M | 98.84M | 156.87M | 107.42M |
| Operating Income | -117.24M | 25.75M | -179.43M | -159.55M | -120.48M |
| Net Income | -181.12M | -24.14M | -220.29M | -245.97M | -227.43M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 313.91M | 256.56M | 292.42M | 238.48M | 226.27M |
| Total Liabilities | 462.3M | 446.88M | 513.25M | 510.29M | 532.7M |
| Total Equity | -148.38M | -190.32M | -220.84M | -271.8M | -306.42M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 214.51M | 465.96M | 413.56M | 313.91M | 226.27M |
| Total Liabilities | 399.1M | 418.05M | 468.46M | 462.3M | 532.7M |
| Total Equity | -211.5M | 47.91M | -54.9M | -148.38M | -306.42M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -224.2M | -38.19M | -76.37M | -129.66M | -158.32M |
| Investing | 3.4M | 229k | -8k | 48k | 27k |
| Financing | 119.87M | 14.83M | 93.91M | 98.47M | 122.84M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -139.1M | 10.15M | -175.37M | -224.2M | -158.32M |
| Investing | -4.44M | -43.15M | -33.61M | 3.4M | 27k |
| Financing | 183.86M | 225.26M | 95.83M | 119.87M | 122.84M |
| Market Cap | 128.59M |
| Price to Earnings Ratio | -0.57 |
| Price to Sales Ratio | 1.2 |
| Price to Cash Ratio | 3.19 |
| Price to Book Ratio | -0.42 |
| Dividend Yield | - |
| Shares Outstanding | 27.42M |
| Average Volume (1 week) | 1.39M |
| Average Volume (1 Month) | 1.65M |
| 52 Week Change | -72.31% |
| 52 Week High | 18.74 |
| 52 Week Low | 1.38 |
| Spread (Intraday) | 0.38 (7.6%) |
| Company Name | Agenus Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.agenusbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
